<i>CCL2</i> Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study

David H. McDermott; Qiong Yang; Sekar Kathiresan; L. Adrienne Cupples; Joseph M. Massaro; John F. Keaney; Martin G. Larson; Ramachandran S. Vasan; Joel N. Hirschhorn; Christopher J. O’Donnell; Philip M. Murphy; Emelia Benjamin

doi:10.1161/circulationaha.105.543579

Shared by

Emelia Benjamin

<i>CCL2</i> Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study

Article 2005 en

Authors

DM
David H. McDermott
QY
Qiong Yang
SK
Sekar Kathiresan

Abstract

1 min read

Our data are consistent with the hypothesis that MCP-1 is involved in the pathogenesis of human atherosclerosis and myocardial infarction.

Related publications

Article2019

Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke

Marios K. Georgakis, Rainer Malik, Harry Björkbacka, Tiberiu A. Pana, Serkalem Demissie, Colby Ayers, Mohamed A. Elhadad, Myriam Fornage, Alexa S. Beiser, Emelia Benjamin, S. Matthijs Boekholdt, Gunnar Engström, Christian Herder, Ron C. Hoogeveen, Wolfgang Köenig, Olle Melander, Marju Orho‐Melander, Alexandru Șchiopu, Martin Söderholm, Nicholas J. Wareham, Christie M. Ballantyne, Annette Peters, Sudha Seshadri, Phyo Kyaw Myint, Jan Nilsson, James A. de Lemos, Martin Dichgans

Article1997

Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.

Carla Zoja, X H Liu, Roberta Donadelli, Mauro Abbate, Davide Testa, Daniela Corna, Giulia Taraboletti, A. Vecchi, Qiang Dong, Barrett J. Rollins, Tullio Bertani, Giuseppe Remuzzi

Article2000

Fibrinogen polymorphisms are not associated with the risk of myocardial infarction

Catharina Jacoba Maria Doggen, Rogier M. Bertina, V. Manger Cats, Frits R. Rosendaal

British Journal of Haematology

Article2020

Association of Circulating Monocyte Chemoattractant Protein–1 Levels With Cardiovascular Mortality

Marios K. Georgakis, James A. de Lemos, Colby Ayers, Biqi Wang, Harry Björkbacka, Tiberiu A. Pana, Barbara Thorand, Caroline Sun, Lana Fani, Rainer Malik, Josée Dupuis, Gunnar Engström, Marju Orho‐Melander, Olle Melander, S. Matthijs Boekholdt, Astrid Zierer, Mohamed A. Elhadad, Wolfgang Köenig, Christian Herder, Ron C. Hoogeveen, Maryam Kavousi, Christie M. Ballantyne, Annette Peters, Phyo Kyaw Myint,

Article1995

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.

Rupert Negus, G. W. H. Stamp, Michele Relf, Frances Burke, Shaivy Malik, Sergio Bernasconi, Paola Allavena, Silvano Sozzani, Alberto Mantovani, Frances R. Balkwill

<i>CCL2</i> Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study

Abstract

Discussion(0)

Related publications

Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke

Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.

Fibrinogen polymorphisms are not associated with the risk of myocardial infarction

Association of Circulating Monocyte Chemoattractant Protein–1 Levels With Cardiovascular Mortality

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.